FENNEC PHARMACEUTICALS INC.
Pedmark, a pharmaceutical compound that reduces chemotherapy-induced hearing loss in children
- Sector
- Biotech
- Headquarters
- RESEARCH TRIANGLE PARK, NC
- Latest Form D
- $7.6M, Jun 2017
- Total capital
- $11.4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $11.4M
- 3 Form D · last Jun 2017
- 113 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 8
- 13 pending · first 2020
- Rank in peer group#196 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$7.6M
- Private capital raisedForm D · SEC · 2nd filing$2.2M
- Private capital raisedForm D · SEC · 1st filing$1.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#196 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Adrian HaighDirectorNamed in SEC Form D filings
- Chris RallisDirectorNamed in SEC Form D filings
- Khalid IslamDirectorNamed in SEC Form D filings
- Krysia LynesExecutive OfficerNamed in SEC Form D filings
- Rostislav RaykovExecutive Officer, DirectorNamed in SEC Form D filings
- Steven SkolskyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 8 granted of 21- PendingTherapeutic Uses For Sodium Thiosulfate FormulationsUSPTOApplication 19275772
- GrantedTherapeutic Uses For Sodium Thiosulfate FormulationsUSPTOUS 12,311,026
- PendingAnhydrous Sodium Thiosulfate and Formulations ThereofUSPTOApplication 18503027
Show all 21 patent records
- Therapeutic Uses For Sodium Thiosulfate FormulationsNov 13, 2025 · Application 19275772Pending
- Therapeutic Uses For Sodium Thiosulfate FormulationsMay 27, 2025 · US 12,311,026Granted
- Anhydrous Sodium Thiosulfate and Formulations ThereofOct 24, 2024 · Application 18503027Pending
- Therapeutic Uses For Sodium Thiosulfate FormulationsJun 4, 2024 · US 11,998,604Granted
- Therapeutic Uses For Sodium Thiosulfate FormulationsMay 28, 2024 · US 11,992,530Granted
- Anhydrous Sodium Thiosulfate and Formulations ThereofMay 23, 2024 · Application 18503035Pending
- Anhydrous Sodium Thiosulfate And Formulations ThereofApr 23, 2024 · US 11,964,018Granted
- Anhydrous Sodium Thiosulfate And Formulations ThereofFeb 8, 2024 · Application 18375162Pending
- Anhydrous Sodium Thiosulfate And Formulations ThereofJun 29, 2023 · Application 18111849Pending
- Anhydrous Sodium Thiosulfate And Formulations ThereofJun 29, 2023 · Application 18111844Pending
- Anhydrous Sodium Thiosulfate And Formulations ThereofJun 29, 2023 · Application 18111845Pending
- Anhydrous Sodium Thiosulfate And Formulations ThereofApr 4, 2023 · US 11,617,793Granted
- Anhydrous Sodium Thiosulfate And Formulations ThereofNov 29, 2022 · US 11,510,984Granted
- Anhydrous Sodium Thiosulfate And Formulations ThereofMay 26, 2022 · Application 17584257Pending
- Anhydrous Sodium Thiosulfate And Formulations ThereofApr 5, 2022 · US 11,291,728Granted
- Anhydrous Sodium Thiosulfate And Formulations ThereofOct 6, 2020 · US 10,792,363Granted
- Formulations Of Anhydrous Sodium ThiosulfateJan 23, 2020 · Application 16458267Pending
- Anhydrous Sodium Thiosulfate And Formulations ThereofApplication PCTUS2019040051Pending
- Formulations Of Anhydrous Sodium ThiosulfateApplication PCTUS2019040052Pending
- Sodium Thiosulfate And Formulations ThereofApplication 62693503Pending
- Sodium Thiosulfate And Formulations ThereofApplication 62693502Pending
Related companies, and why
- MACROGENICS INCSimilar federal contract value in Biotech · null in contracts
- Akebia Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Silo Pharma, Inc.Similar federal contract value in Biotech · null in contracts
- Syrna Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Vitra Labs, Inc.Similar federal contract value in Biotech · null in contracts
- Gut-Brain-Axis Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .